au.\*:("DANHIER, Fabienne")
Results 1 to 7 of 7
Selection :
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug deliveryDANHIER, Fabienne; FERON, Olivier; PREAT, Véronique et al.Journal of controlled release. 2010, Vol 148, Num 2, pp 135-146, issn 0168-3659, 12 p.Article
Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for PaclitaxelDANHIER, Fabienne; MAGOTTEAUX, Nicolas; UCAKAR, Bernard et al.European journal of pharmaceutics and biopharmaceutics. 2009, Vol 73, Num 2, pp 230-238, issn 0939-6411, 9 p.Article
Active and passive tumor targeting of a novel poorly soluble cyclin dependent kinase inhibitor, JNJ-7706621DANHIER, Fabienne; UCAKAR, Bernard; MAGOTTEAUX, Nicolas et al.International journal of pharmaceutics (Print). 2010, Vol 392, Num 1-2, pp 20-28, issn 0378-5173, 9 p.Article
Fluorescent labeling of degradable poly(lactide-co-glycolide) for cellular nanoparticles tracking in living cellsFREICHELS, Hélène; DANHIER, Fabienne; PREAT, Véronique et al.International journal of artificial organs. 2011, Vol 34, Num 2, pp 152-160, issn 0391-3988, 9 p.Conference Paper
PLGA-based nanoparticles: An overview of biomedical applicationsDANHIER, Fabienne; ANSORENA, Eduardo; SILVA, Joana M et al.Journal of controlled release. 2012, Vol 161, Num 2, pp 505-522, issn 0168-3659, 18 p.Article
Paclitaxel-loaded PEGylated PLGA-based nanoparticles : In vitro and in vivo evaluationDANHIER, Fabienne; LECOUTURIER, Nathalie; VROMAN, Benoit et al.Journal of controlled release. 2009, Vol 133, Num 1, pp 11-17, issn 0168-3659, 7 p.Article
Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with PaclitaxelDANHIER, Fabienne; VROMAN, Benoît; LECOUTURIER, Nathalie et al.Journal of controlled release. 2009, Vol 140, Num 2, pp 166-173, issn 0168-3659, 8 p.Article